» Articles » PMID: 20016108

Nurr1 is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons

Abstract

Transcription factors involved in the specification and differentiation of neurons often continue to be expressed in the adult brain, but remarkably little is known about their late functions. Nurr1, one such transcription factor, is essential for early differentiation of midbrain dopamine (mDA) neurons but continues to be expressed into adulthood. In Parkinson's disease, Nurr1 expression is diminished and mutations in the Nurr1 gene have been identified in rare cases of disease; however, the significance of these observations remains unclear. Here, a mouse strain for conditional targeting of the Nurr1 gene was generated, and Nurr1 was ablated either at late stages of mDA neuron development by crossing with mice carrying Cre under control of the dopamine transporter locus or in the adult brain by transduction of adeno-associated virus Cre-encoding vectors. Nurr1 deficiency in maturing mDA neurons resulted in rapid loss of striatal DA, loss of mDA neuron markers, and neuron degeneration. In contrast, a more slowly progressing loss of striatal DA and mDA neuron markers was observed after ablation in the adult brain. As in Parkinson's disease, neurons of the substantia nigra compacta were more vulnerable than cells in the ventral tegmental area when Nurr1 was ablated at late embryogenesis. The results show that developmental pathways play key roles for the maintenance of terminally differentiated neurons and suggest that disrupted function of Nurr1 and other developmental transcription factors may contribute to neurodegenerative disease.

Citing Articles

NURR1 Deficiency Is Associated to Altered Microglial Phenotype in Male Mice.

Montarolo F, Thielens S, Bove M, Bertolotto A, Tempia F, Hoxha E Mol Neurobiol. 2025; .

PMID: 40055293 DOI: 10.1007/s12035-025-04787-8.


JMJD3 deficiency disturbs dopamine biosynthesis in midbrain and aggravates chronic inflammatory pain.

He X, Guo F, Zhang W, Fan J, Le W, Chen Q Acta Neuropathol Commun. 2024; 12(1):201.

PMID: 39716224 PMC: 11664825. DOI: 10.1186/s40478-024-01912-x.


Gene Therapy for Parkinson's Disease Using Midbrain Developmental Genes to Regulate Dopaminergic Neuronal Maintenance.

Kim J, Chang M Int J Mol Sci. 2024; 25(22).

PMID: 39596436 PMC: 11594980. DOI: 10.3390/ijms252212369.


State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons.

Basso V, Dobrossy M, Thompson L, Kirik D, Fuller H, Gates M Biology (Basel). 2024; 13(9).

PMID: 39336117 PMC: 11428604. DOI: 10.3390/biology13090690.


Claustrum and dorsal endopiriform cortex complex cell-identity is determined by Nurr1 and regulates hallucinogenic-like states in mice.

Mantas I, Flais I, Masarapu Y, Ionescu T, Frapard S, Jung F Nat Commun. 2024; 15(1):8176.

PMID: 39289358 PMC: 11408527. DOI: 10.1038/s41467-024-52429-9.


References
1.
Oo T, Kholodilov N, Burke R . Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J Neurosci. 2003; 23(12):5141-8. PMC: 6741204. View

2.
Xu P, Liang R, Jankovic J, Hunter C, Zeng Y, Ashizawa T . Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology. 2002; 58(6):881-4. DOI: 10.1212/wnl.58.6.881. View

3.
Zetterstrom R, Solomin L, Jansson L, Hoffer B, Olson L, Perlmann T . Dopamine neuron agenesis in Nurr1-deficient mice. Science. 1997; 276(5310):248-50. DOI: 10.1126/science.276.5310.248. View

4.
Snyder A, Zigmond M, Lund R . Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J Comp Neurol. 1986; 245(2):274-81. DOI: 10.1002/cne.902450209. View

5.
Ekstrand M, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E . Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A. 2007; 104(4):1325-30. PMC: 1783140. DOI: 10.1073/pnas.0605208103. View